Menu
Back to User profile » Dr Mansour A Alghamdi
Papers published by Dr Mansour A Alghamdi:
Variants in CDHR3, CACNAC1, and LTA Genes Predisposing Sensitivity and Response to Warfarin in Patients with Cardiovascular Disease
Alghamdi MA, AL-Eitan L, Alkhatib R, Al-Assi A, Almasri A, Aljamal H, Aman H, Khasawneh R
International Journal of General Medicine 2021, 14:1093-1100
Published Date: 25 March 2021
Impact of PCSK9, WDR12, CDKN2A, and CXCL12 Polymorphisms in Jordanian Cardiovascular Patients on Warfarin Responsiveness and Sensitivity
Ibdah RK, AL-Eitan LN, Alrabadi NN, Almasri AY, Alnaamneh AH, Khasawneh RH, Alghamdi MA
International Journal of General Medicine 2021, 14:103-118
Published Date: 14 January 2021
Influence of PSRC1, CELSR2, and SORT1 Gene Polymorphisms on the Variability of Warfarin Dosage and Susceptibility to Cardiovascular Disease
AL-Eitan LN, Elsaqa BZ, Almasri AY, Aman HA, Khasawneh RH, Alghamdi MA
Pharmacogenomics and Personalized Medicine 2020, 13:619-632
Published Date: 17 November 2020
Genetic Association of Epilepsy and Anti-Epileptic Drugs Treatment in Jordanian Patients
AL-Eitan LN, Al-Dalala IM, Elshammari AK, Khreisat WH, Nimiri AF, Alnaamneh AH, Aljamal HA, Alghamdi MA
Pharmacogenomics and Personalized Medicine 2020, 13:503-510
Published Date: 16 October 2020
Genetic polymorphisms of CYP3A5, CHRM2, and ZNF498 and their association with epilepsy susceptibility: a pharmacogenetic and case–control study
AL-Eitan LN, Al-Dalalah IM, Mustafa MM, Alghamdi MA, Elshammari AK, Khreisat WH, Al-Quasmi MN, Aljamal HA
Pharmacogenomics and Personalized Medicine 2019, 12:225-233
Published Date: 4 September 2019
Effects of MTHFR and ABCC2 gene polymorphisms on antiepileptic drug responsiveness in Jordanian epileptic patients
AL-Eitan LN, Al-Dalalah IM, Mustafa MM, Alghamdi MA, Elshammari AK, Khreisat WH, Aljamal HA
Pharmacogenomics and Personalized Medicine 2019, 12:87-95
Published Date: 10 June 2019